anticancer drugs

Related by string. Anticancer Drug * Anticancer . AntiCancer : promising anticancer . potent anticancer . XL# anticancer compounds . anticancer agents . anticancer agent . anticancer therapy / Drugs . Drug . DRUG . DRUGS . Druger : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration . Drug Administration FDA . Medicare Prescription Drug * Taxol anticancer drug *

Related by context. All words. (Click for frequent words.) 72 anticancer agents 72 chemotherapeutics 70 chemotherapeutic drugs 70 proteasome inhibitors 68 chemotherapeutic agents 67 PARP inhibitors 66 small molecule inhibitors 66 anticancer therapies 65 chemotherapeutic 65 kinase inhibitors 64 MEK inhibitors 64 chemotherapies 64 taxanes 64 molecularly targeted 64 histone deacetylase inhibitors 64 novel peptide 63 nanocarriers 63 tyrosine kinase inhibitor 63 anticancer therapy 63 biologic therapies 63 multitargeted 63 cytotoxic agents 62 cytotoxic 62 imatinib Gleevec 62 therapies 62 Monoclonal antibodies 62 anticancer 62 selective inhibitors 62 taxol 62 hedgehog pathway 62 nucleoside analogs 62 enzyme inhibitors 62 siRNA therapeutics 62 tyrosine kinase inhibitors 61 chemotherapeutic drug 61 tumor cells 61 HSP# inhibitor 61 immunotherapies 61 Th2 cytokines 61 cancer therapeutics 61 interferons 61 Gefitinib 61 deacetylase inhibitors 61 cytotoxics 61 chemotherapeutic agent 61 monoclonal antibodies 61 HDAC inhibitors 60 biodegradable nanoparticles 60 selective inhibition 60 antitumor 60 aminoglycosides 60 mTOR inhibitors 60 mAbs 60 BAY #-# 60 Pertuzumab 60 VEGF inhibitors 60 angiogenesis inhibitors 60 immunotoxins 60 macrolide antibiotics 60 Pathway Inhibitor 60 gamma secretase inhibitors 59 EGFR inhibitors 59 anticancer agent 59 tubulin binding 59 EGFr 59 Paclitaxel 59 protease inhibitors 59 conventional chemotherapies 59 cilengitide 59 vascular disrupting agents 59 histone deacetylase HDAC inhibitors 59 antiviral therapies 59 anti angiogenesis 59 peptide antigens 59 protein kinase inhibitor 59 angiogenesis inhibitor 59 Doxorubicin 59 tumors 59 HDACs 59 Preclinical studies suggest 59 small molecule 59 HCV protease inhibitors 59 anti angiogenic drugs 59 antibacterial agents 59 tumor antigens 59 neuraminidase inhibitors 59 PI3K inhibitors 59 nanomedicines 59 diseased cells 59 Taxanes 59 TLR agonists 59 glioma cells 59 immunomodulatory 59 echinocandins 59 polyketides 59 peptides 58 nanoparticles 58 polymerase inhibitors 58 radionuclide therapy 58 microtubule inhibitor 58 therapeutics 58 HIV protease inhibitors 58 aptamers 58 IAP inhibitor 58 cyclosporin 58 anticancer compounds 58 therapeutic monoclonal antibodies 58 proteasome inhibitor 58 chemotherapeutic treatments 58 SERMs 58 ErbB3 HER3 58 PARP inhibitor 58 potent inhibitors 58 antisense oligonucleotides 58 CXCR4 receptor 58 Novartis Gleevec 58 A3 adenosine receptor 58 triterpenoids 58 Cisplatin 58 cancer immunotherapy 58 antiangiogenesis 58 oncolytic virus 58 LY# [003] 58 Hsp# inhibitors 58 Camptothecin 58 immune modulators 58 monoclonal antibodies mAbs 58 Mitoxantrone 58 myeloma cells 58 AMN# [001] 58 vitamin D analogs 58 biologic therapeutics 58 liposomes 58 doxorubicin 58 IGF 1R 58 antiangiogenic 58 EGF receptor 58 vinblastine 58 molecularly targeted therapies 58 antimitotic 58 p# inhibitors 58 enzyme inhibitor 58 immunotherapy 58 proteases 58 antifungal drugs 58 BCR ABL inhibitors 58 TNFa 58 antitumoral 58 inhibiting tumor 58 molecular biomarkers 58 nanomolar 58 lapatinib Tykerb 58 cancer immunotherapies 58 VEGFb 58 Herceptin trastuzumab 57 PLX# 57 liposome 57 endostatin 57 Nanobody ® 57 CD# antibody [001] 57 DNA gyrase 57 CDDO Im 57 arsenic trioxide 57 siRNA molecules 57 Vorinostat 57 GAP #B# 57 GSK3 57 renin inhibitors 57 PDGF receptor 57 fusion proteins 57 cancerous cells 57 PI3K inhibitor 57 oral antiviral 57 vorinostat 57 histone deacetylase inhibitor 57 therapeutic monoclonal antibody 57 membrane proteins 57 Vandetanib 57 vinca alkaloids 57 cytostatic 57 Epothilones 57 MDSCs 57 camptothecin 57 interferon IFN 57 fusion inhibitors 57 Cellcept 57 ligands 57 milatuzumab 57 MAbs 57 delta isoform 57 VEGF receptor 57 epothilones 57 Nanobodies ® 57 SARMs 57 integrase inhibitors 57 oncolytic 57 radiolabeled antibodies 57 immune stimulatory 57 viral vectors 57 monoclonal antibody therapies 57 solid tumors 57 trastuzumab Herceptin 57 BCR ABL 57 Rapamycin 57 taxane 57 antineoplastic 57 inhibit angiogenesis 57 Smac mimetic 57 tumor hypoxia 57 TLR9 agonists 57 tyrosine kinase 57 EGFR tyrosine kinase inhibitors 57 Gleevec 57 pentamidine 57 PGE2 57 TLR8 57 anticancer therapeutics 57 humanized monoclonal antibody 57 phosphate S1P 57 proteins peptides 57 HER2 receptors 57 IAP inhibitors 57 MEK inhibitor 57 humanized monoclonal antibodies 57 chimeric monoclonal antibody 57 optimized siRNA 57 humanized antibody 57 nucleoside analogues 56 CETP inhibitors 56 Smac mimetics 56 photosensitizer 56 transfection reagents 56 immune modulatory 56 DFMO 56 ENMD # 56 oncogenes 56 antibody fragment 56 anti angiogenic 56 direct thrombin inhibitors 56 FLT3 56 EGFR 56 Hycamtin 56 therapeutic antibodies 56 Nexavar ® 56 neurotrophic factors 56 immune suppressing 56 antibacterial compounds 56 antisense drugs 56 Gleevec resistant 56 Kinase inhibitors 56 orally bioavailable 56 kinase inhibitor 56 gamma secretase inhibitor 56 EphA2 56 erlotinib Tarceva ® 56 BRAF kinase 56 immunological diseases 56 neurotrophins 56 histone deacetylases 56 dasatinib Sprycel 56 molecules 56 therapeutic proteins 56 immune modulating 56 interleukins 56 insulin sensitizers 56 immunosuppressive regimens 56 azoles 56 prodrugs 56 humanised monoclonal antibody 56 predictive biomarkers 56 siRNA delivery 56 oncolytic viruses 56 mammalian cells 56 inhibit viral replication 56 bortezomib Velcade 56 vinca alkaloid 56 Interferon alpha 56 albumin bound paclitaxel 56 Scorpion venom 56 pharmacologic agents 56 TNF alpha inhibitors 56 drug zotarolimus 56 membrane receptors 56 siRNA 56 BioSilicon 56 resolvins 56 antisense compounds 56 CB2 receptor 56 TRV# [001] 56 superficial bladder cancer 56 forskolin 56 investigational therapies 56 Taxol 56 enveloped viruses 56 disease modifying 56 bacterial enzyme 56 medicinal chemists 56 inhibit tumor 56 integrin receptors 56 tumor antigen 56 antiviral compounds 56 immunomodulator 56 carbohydrate polymer 56 Transcranial Magnetic Stimulation TMS 56 bioactive molecules 56 dexamethasone Decadron 56 synthetic peptides 56 Phylomer ® 56 UsiRNAs 56 cephalosporin antibiotics 56 Squalamine 56 GSK3B 56 oxidative stress inducer 56 proliferative disorders 56 miR #a [002] 56 cediranib 56 MEK ERK 56 bifunctional 56 glioblastoma cells 56 immuno modulatory 56 Crizotinib 56 anti angiogenic agents 56 nanomolar range 56 brain penetrant 56 sd rxRNA 56 anti mitotic 56 antimetastatic 56 nanoparticle 56 antiproliferative 56 Bleomycin 56 dAbs 56 LNP formulations 56 tumor microenvironment 56 specific lectin receptors 56 bevacizumab Avastin ® 56 enzymes 56 tyrosine kinases 56 somatostatin receptors 56 AEG# 56 GPCRs 56 lipid nanoparticles 56 small molecule agonists 56 CBLC# 56 insulin sensitizing 55 pan HDAC inhibitor 55 hormone gastrin 55 PI3K delta 55 bevacizumab Avastin 55 induce apoptosis 55 lentiviral vectors 55 CCL# 55 iRGD 55 rituximab Rituxan 55 potently inhibit 55 pertuzumab 55 macrophage activation 55 TNF alpha antagonist 55 cytotoxic compounds 55 ESBA# 55 xenograft models 55 vincristine 55 etoposide 55 MMP inhibitors 55 adenoviral 55 Dasatinib 55 HCV protease 55 kinases 55 PKCi 55 tubulin inhibitors 55 HIV protease 55 standard chemotherapy regimens 55 anti CD3 antibody 55 HepDirect prodrug 55 endogenous ligands 55 prostanoid 55 antisense 55 glutamate receptors 55 siRNA therapeutic 55 chemopreventive agents 55 Bortezomib 55 MAbs targeting 55 anionic backbone 55 epothilone 55 fluorescent probes 55 cytotoxicity 55 nanoparticulate 55 Panzem 55 REOLYSIN ® 55 HER2 receptor 55 recombinant antibodies 55 adoptive immunotherapy 55 beta2 adrenergic receptor 55 Cyclosporin 55 HuLuc# 55 Protein Kinase C 55 cisplatin 55 rxRNA 55 Erlotinib 55 Novartis AG Gleevec 55 TKIs 55 oral anticancer 55 Erbitux cetuximab 55 SGLT inhibitors 55 proton pump 55 CA4P 55 anti angiogenic therapies 55 protein kinase inhibitors 55 Gleevec imatinib 55 ceramide 55 YONDELIS 55 hormonal therapies 55 interferon 55 neurotrophic 55 paclitaxel 55 SIRT2 55 topotecan 55 topoisomerase 55 VAPRISOL 55 flavopiridol 55 NNRTIs 55 Phenoxodiol 55 photodynamic therapy 55 neuronal nicotinic receptors NNRs 55 galectins 55 Kv#.# 55 neuroendocrine tumors 55 gastrin 55 FK# 55 liposomal doxorubicin 55 pro angiogenic 55 panobinostat 55 antitumour 55 siRNA compounds 55 Abiraterone acetate 55 oncology therapeutics 55 affinity antibodies 55 plasma proteins 55 pegfilgrastim 55 Sym# 55 secretory pathway 55 nanocapsules 55 Nanoshells 55 echinocandin 55 antisense RNA 55 fibrocytes 55 bleomycin 55 protein kinase C 55 nanomaterials 55 EGFR pathway 55 PKM2 55 PKC# 55 selective antagonists 55 antimetabolites 55 anti CD3 55 Imprime PGG 55 Apo2L 55 Genentech Herceptin 55 radiotherapeutic 55 Locked Nucleic Acid LNA 55 secreted protein 55 DHFR 55 CTLA4 Ig 55 nicotinic acetylcholine receptor 55 druggable targets 55 virotherapy 55 immunotoxin 55 antiviral cytokines 55 #HT#A 55 antifungal agents 55 intranasal delivery 55 Tyrima 55 curcumin 55 immunotherapeutics 55 Taxol paclitaxel 55 AKT inhibitor 55 proteins 55 oncoproteins 55 IFNs 55 Vidaza azacitidine 55 intracellular protein 55 Adenosine 55 tumor subtypes 55 PI3K/mTOR 55 ixabepilone 55 2DG 55 alpha interferon 55 Tumour Vascular Disrupting Agent 55 Valproic acid 55 liposomal 55 eflornithine 55 gastrointestinal stromal tumors 55 immunomodulators 55 Rituxan rituximab 55 angiogenesis inhibition 55 antisense oligonucleotide 55 FAAH 55 biodegradable polymers 55 Aurora kinase 55 Cytoxan 54 PXD# 54 targeted antifolate 54 CYT# potent vascular disrupting 54 hypoxia inducible factor 54 treatments 54 synthetic siRNA 54 thalidomide Thalomid 54 antimalarial drug 54 nanocarrier 54 Vidofludimus 54 bispecific antibodies 54 TGF alpha 54 inhibits protein synthesis 54 tubulin inhibitor 54 GPR# agonists 54 erlotinib Tarceva 54 metabolic enzymes 54 HSP# inhibitors 54 vitro assay 54 Alemtuzumab 54 interferon gamma 54 metalloenzymes 54 pRb 54 siRNAs 54 enzastaurin 54 calcineurin inhibitors 54 apoptotic pathway 54 amphotericin B 54 Zolinza 54 chemoresistance 54 prostaglandin synthesis 54 signaling cascades 54 receptor tyrosine kinase inhibitor 54 myeloproliferative disorders 54 salinomycin 54 anti VEGF 54 immunosuppressive 54 neuroblastoma cells 54 Ontak 54 botulinum neurotoxin 54 microwave hyperthermia 54 bioactive lipids 54 Interferon beta 54 PEGylated 54 Enkephalin 54 siRNA binds 54 paclitaxel Taxol 54 sorafenib tablets 54 bacterial enzymes 54 retinoids 54 alkylating agent 54 blood clot dissolving 54 Bevacizumab 54 liposomal formulations 54 synthetic peptide 54 sirtuin enzymes 54 biological molecules 54 anti tubercular 54 CHO cells 54 NF kB pathway 54 malignant cells 54 TNF inhibitors 54 Fibroblast Growth Factor Receptor 54 cellular pathways 54 DsiRNA 54 thrombopoietin 54 retinoic acid 54 pancreatic cancers 54 bryostatin 54 Survivin 54 insulin analogs 54 Carboplatin 54 gefitinib Iressa 54 depsipeptide 54 biomarkers 54 PI3K 54 nifurtimox 54 receptor antagonists 54 P#X# 54 Everolimus 54 peroxisome proliferator activated 54 TACE 54 GPCR targets 54 tyrosine kinase inhibitors TKIs 54 soluble receptor 54 nanospheres 54 Carfilzomib 54 HDACi 54 macrolides 54 nanoparticle formulation 54 RNAi compounds 54 GRP# 54 relapsed ovarian cancer 54 sphingolipids 54 signal transduction inhibitor 54 Liposomal 54 Irinotecan 54 protein therapeutics 54 polyamines 54 anthrax toxin 54 mesothelin 54 DACH platinum 54 antisense molecules 54 Tumor cells 54 prostaglandin D2 54 CRAC channel 54 Etoposide 54 peptidic 54 adenosine receptor 54 ligand TRAIL 54 Darinaparsin 54 anti angiogenic agent 54 HDAC inhibition 54 JAK inhibitors 54 selectively inhibit 54 bioactive compounds 54 Hedgehog pathway 54 RNA antagonists 54 potent anticancer 54 serotonin receptor 54 itraconazole 54 halloysite nanotubes 54 FGFR 54 magnetic nanoparticles 54 Zysolin TM 54 compounds 54 IMC A# 54 Curaxin 54 metastatic cancers 54 sphingolipid 54 Raltegravir 54 novel immunomodulatory 54 EGFR mutant 54 hematopoietic cells 54 antiangiogenic drugs 54 antibody therapeutics 54 small molecule tyrosine 54 selective inhibitor 54 isotypes 54 BRAF inhibitors 54 VEGF 54 Azedra 54 PI3 kinase 54 porphyrins 54 Notch pathway 54 poly ADP ribose polymerase 54 potent cytotoxic 54 nano particles 54 Aviptadil 54 OMP #M# 54 systemic antifungal 54 molecule 54 oxysterols 54 bacterial toxins 54 scorpion venom 54 Gleevec inhibits 54 epithelial tumors 54 humanized antibodies 54 Trastuzumab 54 NKT cells 54 pyrimidines 54 VEGF pathway 54 CD# expressing 54 SGLT2 54 Taxol ® 54 aminoglycoside 54 small molecule activators 54 Sorafenib 54 Tarvacin 54 HGS# 54 monoclonal antibody 54 selectively inhibits 54 Anticalins 54 lectins 54 antagomirs 54 CB1 antagonists 54 HDAC6 54 chemopreventive agent 54 small molecule modulators 54 antibody therapies 54 pharmacokinetic interactions 54 potent antiproliferative 54 CYP #A# 54 therapeutic modalities 54 nucleosides 54 Factor Receptor 53 anti proliferative 53 macrocycles 53 receptor subtype 53 small interfering RNA 53 receptor subtypes 53 M2 subunit 53 Shark cartilage 53 synthetic lethality 53 Olaparib 53 Onconase 53 elastase 53 ganciclovir 53 small molecule inhibitor 53 azacytidine 53 HCV replication 53 Litx 53 prostate tumor 53 cisplatin resistant 53 therapeutic regimens 53 prostaglandin E2 53 Imatinib 53 CCN2 53 defensins 53 triptans 53 Anticalins R 53 Protease inhibitors 53 Vidaza ® 53 novel antibody therapeutics 53 preclinically 53 integrase 53 fluorescent quantum dots 53 tranilast 53 receptor proteins 53 G Protein Coupled 53 derived neurotrophic factor 53 antiangiogenic agents 53 Skp2 53 STAT3 53 glucagon receptor 53 antisense inhibitors 53 Dapagliflozin 53 telomerase inhibitors 53 visilizumab 53 olaparib 53 Debio 53 HDAC 53 BRAF inhibitor 53 carbon nanomaterials 53 imatinib Gleevec ® 53 alfa interferon 53 CLL cells 53 PROCHYMAL 53 cytotoxic therapies 53 ADI PEG 53 uric acid lowering 53 cognitive enhancer 53 Tumor Necrosis Factor 53 TAp# 53 metastatic melanomas 53 multikinase inhibitor 53 glioblastoma 53 ubiquinone 53 chemically modified siRNA 53 antidepressants SSRIs 53 ALK inhibitors 53 carbohydrate polymers 53 cathepsins 53 synthetic retinoid 53 oral anticoagulants 53 Davanat 53 ACAT2 53 glycosylated 53 chemo resistant 53 immune modulator 53 ion channels 53 luteinizing hormone releasing 53 SGLT2 inhibitors 53 Nucleic acids 53 cyclooxygenase 53 antifolate 53 short interfering RNA 53 biotherapeutic 53 Anticalins ® 53 Flt3 53 trans retinoic acid ATRA 53 rifamycins 53 cell signaling pathways 53 Bisphosphonates 53 epithelial cancers 53 mitochondrial toxicity 53 VEGF receptors 53 pancreatic tumors 53 covalent drugs 53 RNAi therapeutic targeting 53 SOD1 53 c MYC 53 suppresses tumor 53 cetuximab Erbitux R 53 TKI therapy 53 tumor vasculature 53 beta interferons 53 Panzem R NCD 53 docetaxel Taxotere ® 53 polyketide 53 anticancer treatments 53 cardiotoxic 53 mAb 53 anti secretory 53 monoclonals 53 HSP# 53 calcitonin 53 Velcade bortezomib 53 neuroblastomas 53 Notch receptors 53 JAK2 inhibitor 53 act synergistically 53 dendrimers 53 endoxifen 53 cMET 53 DXL# 53 monoclonal 53 ASC J9 53 marketed EGFR 53 TLR9 agonist 53 infliximab Remicade 53 allosteric modulators 53 immunotherapeutic agent 53 theranostics 53 amikacin 53 COX enzymes 53 protease inhibitor 53 LLLT 53 molecular abnormalities 53 chaperone protein 53 myelofibrosis polycythemia vera 53 metaglidasen 53 antimetabolite 53 Cytotoxic 53 selective kinase inhibitor 53 TLR9 53 nanocells 53 mimetics 53 potent anti angiogenic 53 DMARDS 53 Th2 cells 53 heparanase 53 glycopeptides 53 chemotherapeutic regimen 53 cyclins 53 biphosphonates 53 Pazopanib 53 microtubule targeting 53 AMPK activators 53 fibrotic disease 53 diagnostic biomarkers 53 Cremophor 53 beta adrenergic 53 integrins 53 androgen receptor 53 NF kappaB activation 53 apoptosis inducing 53 intravesical instillation 53 Immunotherapy 53 recombinant erythropoietin 53 TNF receptors 53 EGFR protein 53 alkylating 53 Metallophile ™ Technology 53 bone morphogenetic proteins 53 MyVax R 53 oncomodulin 53 opiate receptors 53 calcitriol 53 Fludarabine 53 therapeutically relevant 53 accumulate preferentially 53 TLR8 agonist 53 c MET 53 docetaxel Taxotere 53 Ceflatonin 53 CCR2 53 cytotoxin 53 micro RNAs 53 anticlotting 53 investigational humanized monoclonal antibody 53 vivo validation 53 antihypertensive agents 53 protein kinases 53 Sutent sunitinib 53 receptors EGFR 53 biologic therapy 53 druggable target 53 Nexavar sorafenib 53 Tygacil 53 sodium glucose cotransporter 53 VDAs 53 histone methyltransferases HMTs 53 Fc fusion protein 53 telomerase inhibitor 53 stapled peptides 53 chronic viral infections 53 Nedd4 53 glycolipids 53 gene silencing 53 rapamycin 53 chemically modifying 53 primary cilia 53 trans splicing 53 Tamoxifen 53 Kinase Inhibitors 53 Myolimus 53 fumagillin 53 Nanobodies 53 furanones 53 JAK2 53 lung tumors 53 novel anticancer 53 cellular immunotherapy 53 Symadex 53 multi kinase inhibitor 53 IL 1β 53 iPSC 53 Nanobody 53 Glucocorticoids 53 molecularly targeted therapy 53 Theophylline 53 GM CSF 53 GMX# 53 JAK3 53 Factor VEGF 53 Bendamustine 53 sodium stibogluconate 53 GRN#L 53 Xanafide 53 collagens 53 glucocorticoid receptor 53 trans retinoic acid 53 Syk 53 cell signaling pathway 53 endothelin receptor antagonists 53 beta lactamases 53 Fludara ® 53 IgG1 antibody 53 PITs 53 T#I mutant 53 Orally administered 53 Oxaliplatin 53 exon skipping 53 idarubicin 53 JAK2 inhibitors 53 rxRNA ™ compounds 53 TGF beta1 53 Gleevec imatinib mesylate 53 grade gliomas 53 allosteric 53 Curaxins 53 CD# receptor 53 MGd 53 serine protease 53 taxane chemotherapy 53 Degarelix 53 chitinase 53 MediVas 53 p#/CBP 53 Abiraterone 53 multiplex assay 53 Taxotere docetaxel 53 Galectins 53 antisense drug 53 adhesion molecule 53 biomolecules 53 therapeutic peptides 53 Aliskiren 53 THR beta agonist 53 discodermolide 53 NITD# 53 anti emetics 53 Lodamin 53 cytoprotective 52 BMS # 52 molecular underpinnings 52 ubiquitin ligases 52 microbubbles 52 viral proteins 52 collagenase 52 riboswitches 52 parthenolide 52 imatinib 52 naturally occurring molecule 52 polymerase inhibitor 52 bone morphogenetic proteins BMPs 52 prodrug 52 Radiation Therapy SIRT 52 antiapoptotic 52 CORT # 52 PKC alpha 52 DiLA2 52 bisphosphonates 52 sirolimus 52 noncancerous cells 52 IGFBP7 52 glioblastomas 52 Stapled Peptide 52 peptibody 52 gastrointestinal stromal tumors GIST 52 humanised antibody 52 nutlin 52 quinolones 52 chemotherapeutic regimens 52 lipidoid 52 NEUGENE 52 CD# monoclonal antibody 52 JAK#/JAK# 52 PI3K/Akt pathway

Back to home page